Australia's CardieX eyes best day in over 4 months on FDA nod

Conneqt Health

26/04/2023 03:27

** Shares of medical device maker CardieX Ltd  CDX.AX  surge
as much as 25.4% to A$0.420, set for best day since Dec. 9, if
gains hold
    ** Co says U.S. Food and Drug Administration has granted
510(k) clearance for its vascular biometric monitor, CONNEQT
Pulse
    ** Says Pulse provides blood pressure measurements at the
arm and heart as well as other unique vascular biomarkers
    ** Pulse scheduled to be commercially available in Q3 this
year
    ** Stock hits highest since Dec. 13
    ** More than 1 mln shares have changed hands, compared with
30-day average of 75,000 shares 
    ** Stock down ~6.9% so far this year, as of last close 
    


 (Reporting by Upasana Singh in Bengaluru)
 ((Upasana.Singh@thomsonreuters.com))